Palvella Therapeutics (PVLA) Return on Equity [ROE] (2014 - 2026)
Palvella Therapeutics' Return on Equity [ROE] came in at -27.47% for Q2 2026, up 27.45 percentage points from -54.92% a year earlier and up 10.41 percentage points from the prior quarter.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Return on Equity [ROE] (2014 - 2026) Analysis & Trends
For FY2025, Palvella Therapeutics' Return on Equity [ROE] was -92.10%.
- Return on Equity [ROE] carries a five-year change of -1.71 percentage points (FY2020 to FY2025).
- Going back by year, Return on Equity [ROE] was -111.85% in FY2021 (-21.47 pp).
- The Q2 2026 figure represents the highest quarterly Return on Equity [ROE] since Q2 2020.
- The fastest year-over-year change in Return on Equity [ROE] over five years came in Q2 2026 (a gain of 27.45 percentage points), and the weakest in Q3 2021 (a drop of 56.56 percentage points).
- Business Quant data shows PVLA's Return on Equity [ROE] at -37.88% (Q1 2026), -125.15% (Q4 2025) and -76.22% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Palvella Therapeutics | 1.91 Bn | 1.66 Bn | - | -27.47% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -27.47% |
| Mar 31, 2026 | -37.88% |
| Dec 31, 2025 | -125.15% |
| Sep 30, 2025 | -76.22% |
| Jun 30, 2025 | -54.92% |
| Mar 31, 2025 | -39.06% |
| Sep 30, 2023 | -103.58% |
| Jun 30, 2023 | -132.73% |
| Sep 30, 2022 | -107.21% |
| Jun 30, 2022 | -101.82% |
| Mar 31, 2022 | -104.08% |
| Dec 31, 2021 | -99.10% |
| Sep 30, 2021 | -105.88% |
| Jun 30, 2021 | -111.19% |
| Mar 31, 2021 | -101.42% |
| Dec 31, 2020 | -90.80% |
| Sep 30, 2020 | -49.31% |
| Jun 30, 2020 | -24.61% |
| Mar 31, 2020 | -37.52% |
| Dec 31, 2019 | -70.75% |
API Access
Palvella Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();